ProMIS Neurosciences receives Nasdaq notice for MVLS non-compliance

ProMIS Neurosciences Inc.

Received notice from Nasdaq on July 2, 2024, for failing to maintain minimum Market Value of Listed Securities of $35M over 30 consecutive business days.
Has 180 days (until Dec 29, 2024) to regain compliance; MVLS must be at least $35M for ten consecutive business days.
No immediate effect on listing or trading; if not cured, common stock subject to delisting; company may appeal.
Company will monitor market value and consider available options; no assurance of regaining compliance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.